Chrystal U Louis

Chrystal U Louis, MD, MPH, serves as the Chief Medical Officer at TScan Therapeutics. Louis has held significant leadership positions in various pharmaceutical companies, including Senior Vice President of Clinical Development at Zentalis Pharmaceuticals, Vice President and Head of Medical Affairs at CRISPR Therapeutics, and Executive Director of US Medical Affairs for Myeloid Diseases at Bristol Myers Squibb. Additionally, Louis is part of the Boardroom Ready 2022 Cohort with Women In Bio. Academic credentials include a Doctor of Medicine degree from Baylor College of Medicine and a Bachelor of Science degree from the University of California, Davis.